Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingying Bao

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 3, 2024
Ex vivo-generated human CD1c<sup>+</sup> regulatory B cells by a chemically defined system suppress immune responses and alleviate graft-versus-host diseaseYingying Bao, Jialing Liu, Zhishan Li, et al.
Stem Cell Research & Therapy|November 5, 2025
CXCR5-engineered mesenchymal stromal cells home to spleen and mitigate post-sepsis syndrome by preventing secondary infectionJiahao Shi, Lu Zhu, Xin Sui, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 3, 2024
Ex vivo-generated human CD1c<sup>+</sup> regulatory B cells by a chemically defined system suppress immune responses and alleviate graft-versus-host diseaseYingying Bao, Jialing Liu, Zhishan Li, et al.
Stem Cell Research & Therapy|November 5, 2025
CXCR5-engineered mesenchymal stromal cells home to spleen and mitigate post-sepsis syndrome by preventing secondary infectionJiahao Shi, Lu Zhu, Xin Sui, et al.
Pageof 5